Dr. Rishi Kumar Wadhera, MD

Dr. Wadhera practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Wadhera's NPI, 1720372980, was assigned on June 6, 2011. Dr. Wadhera graduated from Mayo Medical School in 2011. Dr. Wadhera holds Massachusetts license 259018.

Dr. Wadhera's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Wadhera's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Dr. Wadhera is also affiliated with Beth Israel Deaconess Hospital-Needham. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Wadhera to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wadhera practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Wadhera's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Wadhera is licensed in Massachusetts.

CMS data shows 375 Medicare services from Dr. Wadhera across 5 procedure codes in 2024, for 290 Medicare patients. Medicare paid $13,711 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 290 Medicare patients who saw Dr. Wadhera in 2024. The largest group is 75 to 84, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wadhera's median patient age at 70, with 48% women.

In 2018, Dr. Wadhera wrote 12 Medicare Part D claims. They cover 1 drug, with $15,170 in total drug cost. In 2016, CMS named 14 claims across 1 drug.

Dr. Wadhera accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 204 papers to Dr. Wadhera, published from 2010 to 2025. 2022 was the busiest year, with 24. The most frequent topics are Medicare, Cardiovascular Diseases and Myocardial Infarction. Dr. Wadhera has published most often in JAMA. Dr. Wadhera's most frequent co-authors are Robert Wayne Yeh, MD, Eric Alexander Secemsky, MD, MS and Daniel Bruce Kramer, MD, MPH.

CMS Open Payments shows 7 general payments to Dr. Wadhera from 2 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 98% of the total. Abbott Laboratories paid the most, $9,093. It also lists 4 research payments totaling $1,330 from 2016 to 2017.

Dr. Wadhera graduated from Mayo Medical School in 2011.